ICRF-193, a catalytic inhibitor of DNA topoisomerase II, delays the cell cycle progression from metaphase, but not from anaphase to the G1 phase in mammalian cells

FEBS Letters

Volumn 406, Issue 3, 1997, Pages 267-270

  Iwai, Miwako ^a,b   Hara, Akira ^b   Andoh, Toshiwo ^c   Ishida, Ryoji ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c SOKA UNIVERSITY   (Japan)

Author keywords

Checkpoint in M phase; ICRF 193; Topoisomerase II inhibitor

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; ANTINEOPLASTIC AGENT; CYCLIN B; DNA TOPOISOMERASE (ATP HYDROLYSING); IRINOTECAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; METAPHASE; NONHUMAN; PRIORITY JOURNAL;

ANAPHASE; ANIMALS; CHO CELLS; CRICETINAE; CYCLINS; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; G1 PHASE; HELA CELLS; HUMANS; METAPHASE; PIPERAZINES;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 0031001702     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00282-2     Document Type: Article

References (27)

1. Weinert T.A., Hartwel L.H. Mol Cell Biol. 10:1990;6554-6564.
2. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., Wahl G.M. Cell. 70:1992;937-948.
3. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Pro. Natl Acad Sci USA. 89:1992;7491-7495.
4. Kastan M.B., Zhan Q.S., El-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. Jr. Cell. 71:1992;587-597.
5. Rieder C.L., Schultz A., Cole R., Sluder G. J Cell Biol. 127:1994;1301-1310.
6. Li X., Nicklas R.B. Nature. 373:1995;630-632.
7. Wang J.C. Annu Rev Biochem. 65:1996;635-692.
8. Holm C., Goto T., Wang J.C., Bostein D. Cell. 41:1985;553-563.
9. Uemura T., Ohkura H., Adachi Y., Morino K., Shiozaki K., Yanagida M. Cell. 50:1987;917-925.
10. Adachi Y., Luke M., Laemmli U.K. Cell. 64:1991;137-148.
11. Shamu C.E., Murray A.W. J Cell Biol. 117:1992;921-934.
12. Tanabe K., Ikegami Y., Ishida R., Andoh T. Cancer Res. 51:1991;4903-4908.
13. Ishida R., Miki T., Narita T., Yui R., Sato M., Utsumi K.R., Tanabe K., Andoh T. Cancer Res. 51:1991;4909-4916.
14. Roca J., Ishida R., Berger J.M., Andoh T., Wang J.C. Proc Natl Acad Sci USA. 91:1994;1781-1785.
15. Ishida R., Sato M., Narita T., Utsumi K.R., Nishimoto T., Morita T., Nagata H., Andoh T. J Cell Biol. 126:1994;1341-1351.
16. Glotzer M., Murray A.W., Kirschner M.W. Nature. 349:1991;132-138.
17. Downes C.S., Clarke D.J., Mullinger A.M., Gimenez-Abian J.F., Creghton A.M., Johnson R.T. Nature. 372:1994;467-470.
18. Timson J. Mutation Res. 47:1977;1-52.
19. Lau C.C., Pardee A.B. Proc Natl Acad Sci USA. 79:1982;2942-2946.
20. Kung A.L., Sherwood S.W., Schimke R.T. J Biol Chem. 268:1993;23072-23080.
21. Steinman K.E., Belinsky G.S., Lee D., Schlegel R. Proc Natl Acad Sci USA. 88:1991;6843-6847.
22. McIntosh J.R. Cold Spring Harbor Symp Quant Biol. 56:1991;613-619.
23. Jordan M.A., Toso R.J., Thrower D., Wilson L. Proc Natl Acad Sci USA. 90:1993;9552-9556.
24. Wendell K.L., Wilson L., Jordan M.A. J Cell Sci. 104:1993;261-274.
25. Sluder G., Miller F.J., Thompson E.A., Wolf D.E. J Cell Biol. 126:1994;189-198.
26. Holm C. Cell. 77:1994;955-957.
27. Gorbsky G.J. Trends Cell Biol. 5:1995;143-148.